PROVIDER PROFILE · NPI 1659506491

Payam SoltanzadehMD

NeurologyLos Angeles, CAI
PRESCRIBING · PART D · 2024
Total Rx claims
1,213
Beneficiaries
Total drug cost
$10.4M
Distinct drugs
18
Brand share
81.5%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
93.7
Quality
86.4
Cost
67.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
Group